NMR Molecular Replacement Provides New Insights into Binding Modes to Bromodomains of BRD4 and TRIM24
Open Access
- 31 March 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 65 (7) , 5565-5574
Abstract
Structure-based drug discovery (SBDD) largely relies on structural information from X-ray crystallography because traditional NMR structure calculation methods are too time consuming to be aligned with typical drug discovery timelines. The recently developed NMR molecular replacement (NMR2) method dramatically reduces the time needed to generate ligand–protein complex structures using published structures (apo or holo) of the target protein and treating all observed NOEs as ambiguous restraints, bypassing the laborious process of obtaining sequence-specific resonance assignments for the protein target. We apply this method to two therapeutic targets, the bromodomain of TRIM24 and the second bromodomain of BRD4. We show that the NMR2 methodology can guide SBDD by rationalizing the observed SAR. We also demonstrate that new types of restraints and selective methyl labeling have the potential to dramatically reduce “time to structure” and extend the method to targets beyond the reach of traditional NMR structure elucidation.Keywords
Funding Information
- AstraZeneca
- Eidgen?ssische Technische Hochschule Z?rich (ETH-40 18-1)
- Universit?t Wien
This publication has 64 references indexed in Scilit:
- Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding SitesJournal of Medicinal Chemistry, 2012
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- Targeting MYC dependence in cancer by inhibiting BET bromodomainsProceedings of the National Academy of Sciences of the United States of America, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- TRIM24 links a non-canonical histone signature to breast cancerNature, 2010
- Selective inhibition of BET bromodomainsNature, 2010
- Trim24 targets endogenous p53 for degradationProceedings of the National Academy of Sciences, 2009
- Scalable molecular dynamics with NAMDJournal of Computational Chemistry, 2005
- Translating the Histone CodeScience, 2001
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996